Dr Datsons Labs Ltd has informed BSE that European pharma firm Mires B.V, which had proposed to buy the Indian firm in April 2014, has completed the valuation of the two plants of Dr Datsons Labs situated at Mahad and Pune, Maharashtra. The total fair valuation of Dr Datsons as stood at Rs 350 crores out of which valuation of the fixed assets of the company stood at Rs 270 Crores. Dr Datsons Labs expects to receive the detailed term sheet for process of proposed acquisition from Mires shortly.
Top Section
Explore Business Standard